The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Sep. 19, 2017
Filed:
Mar. 16, 2015
Applicant:
U.s. Nutraceuticals, Llc, Eustis, FL (US);
Inventors:
John A. Minatelli, Mount Dora, FL (US);
W. Stephen Hill, Ocala, FL (US);
Rudi E. Moerck, Sanford, FL (US);
Assignee:
U.S. NUTRACEUTICALS, LLC, Eustis, FL (US);
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/122 (2006.01); A61K 31/202 (2006.01); A61K 9/48 (2006.01); A61K 31/685 (2006.01); A61K 31/7028 (2006.01); A61K 35/612 (2015.01); A61K 36/05 (2006.01); A61K 36/535 (2006.01); A61K 36/537 (2006.01); A61K 36/55 (2006.01); A61K 45/06 (2006.01); A61K 31/66 (2006.01); A61K 35/60 (2006.01); A23P 10/30 (2016.01); A23L 33/105 (2016.01); A23L 33/115 (2016.01);
U.S. Cl.
CPC ...
A61K 31/122 (2013.01); A23L 33/105 (2016.08); A23L 33/115 (2016.08); A23P 10/30 (2016.08); A61K 9/48 (2013.01); A61K 9/4858 (2013.01); A61K 31/202 (2013.01); A61K 31/66 (2013.01); A61K 31/685 (2013.01); A61K 31/7028 (2013.01); A61K 35/60 (2013.01); A61K 35/612 (2013.01); A61K 36/05 (2013.01); A61K 36/535 (2013.01); A61K 36/537 (2013.01); A61K 36/55 (2013.01); A61K 45/06 (2013.01);
Abstract
A dietary supplement includes comprising a therapeutic amount of astaxanthin derived from a synthetic or natural ester or diol, and at least one of a phospholipid, glycolipid, and sphingolipid, and formulated into an oral dosage form, wherein the astaxanthin is 0.1 to 15 percent by weight of the at least one phospholipid, glycolipid, and sphingolipid. The composition includes 0.5 to 12 mg of astaxanthin and may be used to treat low density lipoprotein (LDL) oxidation in humans and other diseases, disorders and impairments.